Background: Drug-induced interstitial lung disease (DIILD) occurs as a result of numerous
agents, but the risk often only becomes apparent after the marketing authorisation of such …

Rheumatoid arthritis-associated lung disease | European Respiratory Society Skip to main
content Main menu Home Current issue Past issues Authors/reviewers Instructions for authors …

Objective Methotrexate has shown efficacy for the treatment of several diseases, especially
rheumatoid arthritis (RA). Methotrexate has also been implicated as a causative agent in …

Objectives To examine the effectiveness of Janus-kinase inhibitors (JAKis) or abatacept
(ABA) in patients with rheumatoid arthritis-interstitial lung disease (RA-ILD). Methods …

Interstitial lung disease (ILD) accounts for the major cause of morbidity and mortality in
rheumatoid arthritis (RA). However, little is known of the pathogenesis, diagnosis and …

Background Interstitial lung disease (ILD) is the most severe extra‐articular manifestation of
rheumatoid arthritis (RA). Although it is responsible of 10–20% of all RA mortality, no …

Rheumatoid arthritis (RA) is a chronic and systemic inflammatory disease affecting 0.5–1%
of the population worldwide. Interstitial lung disease (ILD) is a serious pulmonary …

Background Interstitial lung disease (ILD) is a serious complication that represents the
second leading cause of death in patients with rheumatoid arthritis (RA). Treatment of RA …

Introduction: Biological drugs are therapies designed to target a specific molecule of the
immune system that have been linked with the development of autoimmune diseases. Areas …

Interstitial lung disease (ILD) and pulmonary fibrosis comprise a wide array of inflammatory
and fibrotic lung diseases which are often confusing to general medicine and pulmonary …